For Planning Authorities Sample Clauses

For Planning Authorities. 5.3.1 Development Corporations - How the Draft Planning Agreement Promotes its Statutory Responsibilities N/A 5.3.2 Other Public Authorities – How the Draft Planning Agreement Promotes the Objects (if any) of the Act under Which it is Constituted N/A
Sample 1
AutoNDA by SimpleDocs
For Planning Authorities. 4.3.1 Development Corporations - How the Planning Agreement Promotes its Statutory Responsibilities N/A
Sample 1
For Planning Authorities. Development Corporations - How the Draft Planning Agreement Promotes its Statutory Responsibilities N/A Other Public Authorities – How the Draft Planning Agreement Promotes the Objects (if any) of the Act under which it is Constituted N/A Councils – How the Draft Planning Agreement Promotes the Elements of the Council’s Charter The Draft Planning Agreement:  promotes the provision of adequate, equitable and appropriate services and facilities for the community by making provision for community infrastructure,  facilitates involvement of the community in decision making regarding the provision of community infrastructure, and  secures funding for community infrastructure for which it is provided to meet the needs of residents within the locality. All Planning Authorities – Whether the Draft Planning Agreement Conforms with the Authority’s Capital Works Program CAN_CAN00309_082.doc 00 Xxxxxx Xxxx Precinct B Planning Agreement – Deed of Variation City of Canada Bay Council Billbergia Developments Pty Ltd Waterpoint Site 1 Lessor Pty Ltd Waterpoint Site 2 Lessor Pty Ltd Execution Executed as an Agreement Dated: Executed on behalf of the Council General Manager Witness/Name/Position Executed on behalf of the Developer in accordance with s127(1) of the Corporations Act (Cth) 2001 Name/Position Name/Position Xxxxxx West Precinct B Planning Agreement – Deed of Variation City of Canada Bay Council Billbergia Developments Pty Ltd Waterpoint Site 1 Lessor Pty Ltd Waterpoint Site 2 Lessor Pty Ltd Executed on behalf of Waterpoint Site 1 Lessor in accordance with s127(1) of the Corporations Act (Cth) 2001 Name/Position Name/Position Executed on behalf of Waterpoint Site 2 Lessor in accordance with s127(1) of the Corporations Act (Cth) 2001 Name/Position Name/Position Xxxxxx West Precinct B Planning Agreement – Deed of Variation City of Canada Bay Council Billbergia Developments Pty Ltd Waterpoint Site 1 Lessor Pty Ltd Waterpoint Site 2 Lessor Pty Ltd Appendix (Clause 9) Environmental Planning and Assessment Regulation 2000 (Clause 25E) Explanatory Note Draft Deed of Variation to Planning Agreement Under cl25C(3) of the Environmental Planning and Assessment Regulation 2000 Parties City Of Canada Bay Council ABN 79 130 029 350 of Xxxxx Xxxxxx, Xxxxxxxxxxx Xxxxxx, Xxxxxxxxx, XXX, 0000 (Council) Waterpoint Site 1 Lessor Pty Ltd ACN 113 526 060 of Xxxxx 0, 00 Xxxxx Xxxxxx, Xxxxxxxxxx, XXX, 0000 (Waterpoint 1) Waterpoint Site 2 Lessor Pty Ltd ACN 113 526 104 of Xxxxx 0, 00...
Sample 1
For Planning Authorities. Development Corporations – How the Planning Agreement promotes its statutory responsibilities Not Applicable Other Public Authorities – How the Planning Agreement promotes the objects (if any) of the Act under which it is constituted Not Applicable Councils – How the Planning Agreement promotes the elements of the Council’s Charter Not Applicable All Planning Authorities – Whether the Planning Agreement conforms with the Authority’s Capital Works Program Not applicable
Sample 1
For Planning Authorities. Development Corporations - How the Draft Planning Agreement Promotes its Statutory Responsibilities N/A Other Public Authorities – How the Draft Planning Agreement Promotes the Objects (if any) of the Act under which it is Constituted N/A Councils – How the Draft Planning Agreement Promotes the Elements of the Council’s Charter (now the Principles for Local Government Contained in Chapter 3 of the Local Government Act 1993) The Draft Planning Agreement promotes the principles for local government by: • ensuring that effective and efficient services are provided to meet the needs of the local community • ensuring that land and assets are properly manage lands so that current and future local community needs can be met in an affordable way, • setting out how the Council works with others to secure appropriate services for local community need, • actively engaging the local and wider community by informing them about its activities through public notification.
Sample 1
For Planning Authorities. Development Corporations - How the Draft Planning Agreement Promotes its Statutory Responsibilities N/A Other Public Authorities – How the Draft Planning Agreement Promotes the Objects (if any) of the Act under which it is Constituted N/A Councils – How the Draft Planning Agreement Promotes the Elements of the Council’s Charter (now the Principles for Local Government Contained in Chapter 3 of the Local Government Act 1993) The Draft Planning Agreement promotes the principles for local government by:  ensuring that effective and efficient services are provided to meet the needs of the local community  ensuring that land and assets are properly manage lands so that current and future local community needs can be met in an affordable way,  setting out how the Council works with others to secure appropriate services for local community need,  actively engaging the local and wider community by informing them about its activities through public notification. All Planning Authorities – Whether the Draft Planning Agreement Conforms with the Authority’s Capital Works Program All land dedications are for the purpose of providing public works. As such the planning agreement conforms with the Council’s Capital Works Program. All Planning Authorities – Whether the Draft Planning Agreement specifies that certain requirements must be complied with before a construction certificate, occupation certificate or subdivision certificate is issued
Sample 1
For Planning Authorities. 5.3.1 Development corporations - How the proposed Planning Agreement promotes its statutory responsibilities Not relevant.
Sample 1
AutoNDA by SimpleDocs
For Planning Authorities 
Sample 1

Related to For Planning Authorities

  • Signing Authority Will the above-named Partner be able to sign contracts on behalf of the Partnership? ☐ Yes ☐ No Partner 3: with a mailing address of . a.) Ownership: %

  • Regulatory Authorities Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, the Company and its subsidiaries: (i) are in compliance in all material respects with all statutes, rules, regulations, ordinances, orders and decrees applicable to the ownership, testing, in humans or laboratory models, development, manufacture, formulation, packaging, processing, recordkeeping, use, distribution, marketing, labeling, promotion, sale, price reporting, reimbursement, storage, import, export or disposal of any product manufactured or distributed by or for the Company or any of its subsidiaries (“Applicable Laws”), except where the failure to so comply would not, individually or in the aggregate, result in a Material Adverse Effect; (ii) to the knowledge of Company and its subsidiaries, have not, either voluntarily or involuntarily, disclosed to any governmental authority any violations of Applicable Laws, except such as would not, individually or in the aggregate, result in a Material Adverse Effect; (iii) have not received any Food and Drug Administration (“FDA”) Form 483 or any foreign counterpart thereof, warning letter, clinical hold notice or untitled letter from the FDA, any Institutional Review Board (as defined by federal regulation at 21 CFR Section 56.102(g)) or any other governmental authority alleging or asserting noncompliance with any Applicable Laws or any licenses, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”), except such as would not, individually or in the aggregate, result in a Material Adverse Effect; (iv) have not received notification of nor have reason to believe that any audits by a governmental authority have resulted in a determination that any of their respective products have been improperly reimbursed, except such audits and determinations as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (v) possess all Authorizations (including, without limitation, exemptions under any Investigational Device Exemption or Investigational New Drug Application, as described at 21 CFR Sections 312 and 812, and approvals of any Institutional Review Board), which are in full force and effect, required for the conduct of their respective businesses (and such Authorizations are valid and in full force and effect) and are not in violation of any term of any such Authorizations, except where the failure to possess such Authorization or the violation of such Authorization would not, individually or in the aggregate, result in a Material Adverse Effect; (vi) have not received written notice of any pending or threatened claim, suit, proceeding, clinical hold, hearing, enforcement, audit, investigation, arbitration, suspension, debarment or exclusion from any governmental authority or Institutional Review Board alleging that any of their respective operations or activities is in violation of any Applicable Laws or Authorizations and the Company has no knowledge or reason to believe that any such governmental authority, Institutional Review Board or other non-governmental authority is considering any such claim, suit, proceeding, clinical hold, hearing, enforcement, audit, investigation, arbitration, suspension, debarment or exclusion except for any such claims, suits, proceedings, clinical holds, hearings, enforcements, audits, investigations, arbitrations, suspensions, debarments or exclusions that would not, individually or in the aggregate, result in a Material Adverse Effect; (vii) have not received written notice that any governmental authority or Institutional Review Board has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and the Company has no knowledge or reason to believe that any such governmental authority is considering such action, except for any such actions that would not, individually or in the aggregate, result in a Material Adverse Effect; (viii) have, or have had on their behalf, filed, declared, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as are required by any Applicable Laws or Authorizations, except where the failure to so file, declare, obtain, maintain or submit would not, individually or in the aggregate, result in a Material Adverse Effect and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission); and (ix) have not, either voluntarily or involuntarily, initiated, conducted or issued, or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, warning, “dear doctor” letter or investigator notice relating to an alleged lack of safety or efficacy of any product or product candidate, any alleged product defect, or violation of any material Applicable Laws or Authorizations and the Company is not aware of any facts that would cause the Company or any of its subsidiaries to initiate any such notice or action and the Company has no knowledge or reason to believe that any governmental authority, Institutional Review Board or other non-governmental authority intends to initiate any such notice or action, except for any such notices or actions that would not, individually or in the aggregate, result in a Material Adverse Effect. Any clinical trials conducted by or on behalf of the Company or any of its subsidiaries that are described in the Registration Statement, the General Disclosure Package or the Prospectus were and, if still pending, are being conducted in compliance in all material respects with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all applicable federal, state, local and foreign laws, rules and regulations, including, but not limited to, the Federal Food, Drug, and Cosmetic Act and implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and 312. Any descriptions of studies, tests and preclinical and clinical trials, including any related results and regulatory status, contained in the Registration Statement, the General Disclosure Package or the Prospectus are, and will be, accurate and complete in all material respects. The Company is not aware of any studies, tests or trials the results of which reasonably call into question in any material respect the clinical trial results described or referred to in the Registration Statement, the General Disclosure Package or the Prospectus. Neither the Company nor any of its subsidiaries has received any written notices or other correspondence from the FDA, an Institutional Review Board or other governmental agency requiring or recommending the termination, suspension or material modification of any clinical trials conducted by, or on behalf of, the Company or any of its subsidiaries or in which the Company or any of its subsidiaries has participated.

  • Requisite Regulatory Approvals All Consents required to be obtained from or made with any Governmental Authority in order to consummate the transactions contemplated by this Agreement shall have been obtained or made.

  • Competent Authorities The Parties shall inform each other about the structure, organisation and division of competences of their competent authorities during the first meeting of the Sanitary and Phytosanitary Sub-Committee referred to in Article 65 of this Agreement ("SPS Sub-Committee"). The Parties shall inform each other of any change of the structure, organisation and division of competences, including of the contact points, concerning such competent authorities.

  • Procurement Planning Prior to the issuance of any invitations to bid for contracts, the proposed procurement plan for the Project shall be furnished to the Association for its review and approval, in accordance with the provisions of paragraph 1 of Appendix 1 to the Guidelines. Procurement of all goods and works shall be undertaken in accordance with such procurement plan as shall have been approved by the Association, and with the provisions of said paragraph 1.

  • Regulatory Applications (a) Sky and Metropolitan and their respective Subsidiaries shall cooperate and use their respective reasonable best efforts to prepare, within 45 days of the execution of this Agreement, all documentation and requests for regulatory approval, to timely effect all filings and to obtain all permits, consents, approvals and authorizations of all third parties and Governmental Authorities and Regulatory Authorities necessary to consummate the transactions contemplated by this Agreement. Each of Sky and Metropolitan shall have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, with respect to, and shall be provided in advance so as to reasonably exercise its right to review in advance, all material written information submitted to any third party or any Governmental Authority or Regulatory Authority in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto agrees to act reasonably and as promptly as practicable. Each party hereto agrees that it will consult with the other party hereto with respect to the obtaining of all material permits, consents, approvals and authorizations of all third parties and Governmental Authorities or Regulatory Authorities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other party apprised of the status of material matters relating to completion of the transactions contemplated hereby.

  • Cooperation with supervisory authorities 1. The data exporter agrees to deposit a copy of this contract with the supervisory authority if it so requests or if such deposit is required under the applicable data protection law.

  • Other Regulatory Approvals Each party hereto shall cooperate and use its reasonable best efforts to promptly prepare and file all necessary documentation to effect all necessary applications, notices, petitions, filings and other documents, and use all reasonable efforts to obtain (and will cooperate with each other in obtaining) any consent, acquiescence, authorization, order or approval of, or any exemption or nonopposition by, any Governmental Entity required to be obtained or made by Parent or the Company or any of their respective Subsidiaries in connection with the Offer and the Merger or the taking of any other action contemplated by this Agreement.

  • Regulatory Approval 25.1 The Parties understand and agree that this Agreement and any amendment or modification hereto will be filed with the Commission for approval in accordance with Section 252 of the Act and may thereafter be filed with the FCC. The Parties believe in good faith and agree that the services to be provided under this Agreement are in the public interest. Each Party covenants and agrees to fully support approval of this Agreement by the Commission or the FCC under Section 252 of the Act without modification.

  • Regulatory Approvals All Requisite Regulatory Approvals shall have been obtained and shall remain in full force and effect and all statutory waiting periods in respect thereof shall have expired, and no such Requisite Regulatory Approval shall have resulted in the imposition of any Materially Burdensome Regulatory Condition.

Time is Money Join Law Insider Premium to draft better contracts faster.